Bart Roelf Jan van Dijken

6PUBLICATIONS
3CO-AUTHORS
Medical infection agents (incl. prions)Medical biochemistry - inorganic elements and compoundsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 28, 2023
Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More?

Bart R J van Dijken, Annerieke R Doff, Roelien H Enting

|Sep 09, 2023
The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma.

Bart R J van Dijken, Hanne-Rinck Jeltema, Justyna Kłos

|May 03, 2023
Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients.

Jesse D de Groot, Bart R J van Dijken, Hiska L van der Weide

|Feb 25, 2022
Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.

Bart R J van Dijken, Alfred O Ankrah, Gilles N Stormezand

|Jun 11, 2021
Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma.

Bart R J van Dijken, Bram Schuuring, Hanne-Rinck Jeltema

Pageof 1

Frequent Collaborators

3 joint publications

Anouk van der Hoorn

2 joint publications

Hanne-Rinck Jeltema

1 joint publications

Wilfred F A Den Dunnen